Td Asset Management Inc Kronos Bio, Inc. Transaction History

Td Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$6.26 - $14.42 $247,608 - $570,368	-39,554 Reduced 72.21%	15,219 $110,000
Q2 2021 Aug 11, 2021	BUY	$20.08 - $29.02 $440,474 - $636,582	21,936 Added 66.8%	54,773 $1.12 Million
Q1 2021 May 14, 2021	BUY	$27.0 - $32.48 $87,075 - $104,747	3,225 Added 10.89%	32,837 $961,000
Q4 2020 Feb 16, 2021	BUY	$26.68 - $38.23 $790,048 - $1.13 Million	29,612 New	29,612 $885,000

19.8M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $48.8M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.